Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands†
References (68)
- et al.
Evolution and emergence of Bordetella in humans
Trends Microbiol.
(2005) - et al.
The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys
J Infect.
(2006) Update on adolescent immunization: Review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis
J Pediatr Health Care.
(2006)- et al.
Pertussis in young infants: Apnoea and intra-familial infection
Clin Microbiol Infect.
(2007) - et al.
The case for maternal vaccination against pertussis
Lancet Infect Dis.
(2007) Maternal vaccination against pertussis
Lancet Infect Dis.
(2008)Maternal vaccination against pertussis
Lancet Infect Dis.
(2008)Health Care Insurance Board
- et al.
Cost-effectiveness of adult pertussis vaccination in Germany
Vaccine.
(2008)
ClinicalTrials.gov
Prevention of pertussis
Semin Respir Infect.
Health burden of pertussis in adolescents and adults
Pediatr Infect Dis J.
Pertussis in infants: Preventing deaths and hospitalisations in the very young
J Paediatr Child Health.
New pertussis vaccination strategies beyond infancy: Recommendations by the global pertussis initiative
Clin Infect Dis.
Widespread silent transmission of pertussis in families: Antibody correlates of infection and symptomatology
J Infect Dis.
Pertussis disease burden in the household: How to protect young infants
Clin Infect Dis.
Source of infection in household transmission of culture-confirmed pertussis in Brazil
Pediatr Infect Dis J.
Infant pertussis: Who was the source?
Pediatr Infect Dis J.
Epidemiological features of pertussis in hospitalized patients in Canada, 1991–1997: Report of the Immunization Monitoring Program-Active (IMPACT)
Clin Infect Dis.
Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines
Microbiology.
Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in the Netherlands
Pediatr Infect Dis J.
Seasonal patterns in time series of pertussis
Epidemiol Infect.
Pertussis in the Netherlands [in Dutch]
Ned Tijdschr Geneeskd.
Duration of immunity against pertussis after natural infection or vaccination
Pediatr Infect Dis J.
Pertussis sources of infection and routes of transmission in the vaccination era
Pediatr Infect Dis J.
Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT
Clin Infect Dis.
Efficacy of an acellular pertussis vaccine among adolescents and adults
N Engl J Med.
Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age
Pediatr Infect Dis J.
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants
J Pediatr.
Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine
J Pediatr.
Prospective multinational study of pertussis infection in hospitalized infants and their household contacts
Pediatr Infect Dis J.
Transmission of Bordetella pertussis to young infants
Pediatr Infect Dis J.
Cited by (54)
Applying a Constrained Optimization Portfolio Model to Aid Prioritization of Public Health Interventions in Malaysia
2020, Value in Health Regional IssuesRecommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update
2018, VaccineCitation Excerpt :An affordable ap vaccine for pregnant women would substantially reduce infant disease burden. Maternal immunization with ap-containing vaccines has been reported to be cost-effective in many studies [42–44] (see Table 3). wP vaccines are effective, despite being more reactogenic than aP vaccines and requiring more quality control.
Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil
2016, VaccineCitation Excerpt :Estimates of pertussis incidence used in our base case were based on confirmed cases reported to SINAN. We did not apply any correction to SINAN figures, assuming surveillance had adequate sensitivity to detect cases in infants, an assumption also made by other authors [26]. However, underreporting may occur.
- †
Presented in part at the 12th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research, October 24–27, 2009, in Paris, France.